Pre-Submission Review for Global Health Papers

Global health reviewers often ask:

• who defined the research question?
• are local collaborators, institutions, and communities represented fairly?
• does the author list reflect the work and setting?
• is the setting described deeply enough for interpretation?
• are ethics, consent, governance, and data-sharing constraints clear?
• does the manuscript use the right reporting guideline?
• are policy or implementation claims proportionate to the evidence?
• does the paper avoid implying that results from one setting generalize everywhere?
• does the target journal match the global health contribution?

The paper has to be scientifically credible and ethically credible.

In our pre-submission review work, global health manuscripts most often fail when the research is relevant but the manuscript underdevelops context, equity, or partnership.

Extractive framing: the paper studies an LMIC setting but gives little evidence of local intellectual contribution or setting-specific interpretation.

Context gap: health-system constraints, financing, geography, workforce, conflict, language, culture, or access barriers are treated as background rather than part of the finding.

Policy leap: the discussion recommends global policy from a narrow design or one local implementation.

Equity thinness: disparities are named, but the mechanism and practical consequence are not analyzed.

Reporting mismatch: the study needs CONSORT, STROBE, PRISMA, RECORD, COREQ, TIDieR, or another checklist, but the manuscript does not make that transparent.

A useful review should identify whether the first objection will be scientific, ethical, contextual, or journal-fit related.

PLOS Global Public Health describes itself as a global forum for public health research across disciplines and regional boundaries, focused on major health challenges and inequities. Its submission guidance emphasizes author affiliations, contribution statements, human-subjects ethics, trial protocols, trial registration, CONSORT materials, and reporting standards for specific study types.

PLOS reporting guidance also says authors doing research in other countries and communities should ensure local collaborators are appropriately acknowledged in authorship or acknowledgments. BMJ reporting guidance directs authors to use study-design-specific reporting guidelines.

Those signals make global health readiness different from generic public health readiness.

Send the manuscript, target journal, protocol, reporting checklist, ethics approvals, partnership or community-engagement details, author contribution notes, data-sharing constraints, setting description, policy or implementation claims, statistical analysis plan, and prior reviewer comments if available.

If the paper involves multiple countries or LMIC sites, include site-specific context and explain how interpretation differs by setting.

A useful global health pre-submission review should include:

• global-health contribution verdict
• equity and partnership critique
• setting-context review
• ethics and governance check
• reporting-guideline check
• policy and implementation-language review
• journal-lane recommendation
• submit, revise, retarget, or diagnose deeper call

The review should not only say "add equity." It should identify the equity or partnership issue that could undermine trust.

Before submission, authors often need to:

• move setting context earlier in the manuscript
• clarify local collaborator and community roles
• make ethics and data-governance statements more specific
• narrow policy claims to the studied setting
• explain what does and does not generalize
• add the correct reporting checklist
• strengthen implementation or health-system interpretation
• retarget from a global health journal to public health, epidemiology, infectious disease, implementation, or specialty clinical venues

These fixes help the manuscript avoid looking extractive, generic, or overclaimed.

A trial needs protocol, registration, CONSORT materials, context, implementation constraints, and equity interpretation. An observational study needs STROBE or RECORD discipline, bias handling, data provenance, and generalizability restraint. A qualitative study needs sampling, reflexivity, ethics, and context depth. A policy paper needs stakeholder relevance and decision consequences. A cross-country paper needs comparability logic and careful avoidance of false equivalence. An implementation paper needs fidelity, adaptation, and local feasibility.

The AI manuscript review can flag whether the blocking risk is equity, partnership, reporting, policy language, or journal fit.

Use this page when the manuscript's submission risk depends on global health equity, LMIC context, cross-country interpretation, local partnership, global policy, or implementation in resource-constrained settings. Use public health review when the paper is mainly domestic population health, prevention, community health, or policy without a global health equity frame.

That distinction keeps the page focused on the global health buyer's actual problem.

Do not submit a global health paper if the manuscript has not made local context and partnership visible. Reviewers may read that omission as a scientific weakness and an equity weakness at the same time.

Also pause if a local result is written as a global recommendation without explaining the mechanism that would let the finding travel. Global health journals value actionability, but actionability depends on setting, system, and implementation reality.

For multi-country work, pause again if the manuscript treats sites as interchangeable. A comparison across regions, clinics, ministries, or surveillance systems needs to explain which differences are methodological noise and which differences are part of the global health finding. Otherwise, reviewers may see the analysis as pooled convenience rather than cross-setting evidence.